Hence, despite an initial growth retardation after TLR3 activation, the acquisition of CSC phenotypes in the remaining tumor cells could engender a stronger and more robust ‘second wave' of tumor growth (greater than 100-fold, Figure 3d). This evidence concerns the gene TLR3 and neoplasm.